Clover Biopharmaceuticals (HKSE:02197) EPS (Basic): HK$-0.18 (TTM As of Dec. 2025)


HKSE:02197 Clover Biopharmaceuticals Ltd HKSE:02197
21 GF Score
Price HK$1.83
! 4 Warning Signs
View Full Analysis

What is Clover Biopharmaceuticals EPS (Basic)?

Clover Biopharmaceuticals HKSE:02197 +2.23% 21 EPS (Basic) is HK$-0.18 as of Dec. 2025. GuruFocus rates HKSE:02197 with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

Clover Biopharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was HK$-0.09. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.18.

Clover Biopharmaceuticals's EPS (Diluted) for the six months ended in Dec. 2025 was HK$-0.09. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.18.

Clover Biopharmaceuticals's EPS without NRI for the six months ended in Dec. 2025 was HK$-0.09. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -0.17.

During the past 3 years, the average EPS without NRI Growth Rate was 55.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Clover Biopharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 77.00% per year. The lowest was -244.30% per year. And the median was 55.10% per year.

Clover Biopharmaceuticals  (HKSE:02197) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Clover Biopharmaceuticals EPS (Basic) Related Terms

Clover Biopharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Clover Biopharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Biopharmaceuticals EPS (Basic) Chart

Clover Biopharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial -15.94 -2.48 -0.12 -0.77 -0.18

Clover Biopharmaceuticals Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.69 -0.09 -0.68 -0.09 -0.09
HKSE:02197
21GF Score
Clover Biopharmaceuticals Ltd HKSE:02197
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Biopharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Clover Biopharmaceuticals's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-226.57-0)/1260.363
=-0.18

Clover Biopharmaceuticals's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-114.695-0)/1261.766
=-0.09

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$-0.18 mean?
Clover Biopharmaceuticals (HKSE:02197) has a EPS (Basic) of HK$-0.18 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Clover Biopharmaceuticals and its competitors.
Is Clover Biopharmaceuticals' EPS (Basic) too high?
Clover Biopharmaceuticals' current EPS (Basic) is HK$-0.18. Overall, Clover Biopharmaceuticals has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Clover Biopharmaceuticals' EPS (Basic) compare to VRTX and REGN?
Clover Biopharmaceuticals' EPS (Basic) of HK$-0.18 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Clover Biopharmaceuticals and its competitors. Clover Biopharmaceuticals's current EPS (Basic) is HK$-0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Biopharmaceuticals stock overvalued right now?
Clover Biopharmaceuticals (HKSE:02197) has a current EPS (Basic) of HK$-0.18. The current EPS (Basic) is HK$-0.18. Clover Biopharmaceuticals' overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Clover Biopharmaceuticals (HKSE:02197), the current EPS (Basic) is HK$-0.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clover Biopharmaceuticals Business Description

Address No. 758 West Nanjing Road, Room 1901, Jing’an District, Shanghai, CHN
Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to unleashing the power of vaccines to save lives and improve health around the world. The leverage the proprietary Trimer-Tag technology platform to conduct R&D for vaccines that can fulfill unmet needs, with a focus on building a respiratory vaccine franchise to reduce the burden of vaccine-preventable diseases. The Group has only one operating segment, which is the research and development, manufacturing, and commercialisation of vaccines. Geographically, the company earns revenue from Mainland China and Korea.
21GF Score

Get the complete analysis for HKSE:02197

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.83
Price